In accordance with Executive Order 12866, the analyses describe the regulatory options available to reduce the risk of an outbreak of BSE in the United States and the costs and benefits associated with each option.
The analysis describes the regulatory options that are available to reduce the risk of an outbreak of BSE in ths US, most of which involve pharmaceuticals.